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Study Objectives: Disrupted sleep is one of the prominent but often overlooked presenting symptoms in the clinical course of psychotic disorders. The aims 
of this study were to examine the prevalence of sleep disturbances, particularly insomnia and nightmares, and their prospective associations with the risk of 
suicide attempts in patients with schizophrenia-spectrum disorders.
Methods: A naturalistic longitudinal study was conducted in outpatients diagnosed with schizophrenia-spectrum disorders recruited from the psychiatric 
outpatient clinic of a regional university-affiliated public hospital in Hong Kong. A detailed sleep questionnaire was completed by 388 patients at baseline in 
May–June 2006. Relevant clinical information was extracted from clinical case notes from June 2007–October 2014.
Results: Prevalence of frequent insomnia and frequent nightmares was 19% and 9%, respectively. Baseline frequent insomnia was significantly associated 
with an increased incidence of suicide attempts during the follow-up period (adjusted hazard ratio = 4.63, 95% confidence interval 1.40–15.36, P < 0.05). 
Nightmare complaint alone did not predict the occurrence of suicide attempts, but the comorbidity of nightmares and insomnia was associated with the risk of 
suicide attempt over follow-up (adjusted HR = 11.10, 95% confidence interval: 1.68–73.43, P < 0.05).
Conclusions: Sleep disturbances are common in patients with schizophrenia-spectrum disorders. The association between sleep disturbances and suicidal 
risk underscores the need for enhanced clinical attention and intervention on sleep disturbances in patients with schizophrenia.
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INTRODUCTION
Sleep disturbances, one of the most common presenting com-
plaints in psychiatric patients, are often associated with sub-
stantial personal distress, pronounced impairment of daytime 
functioning, reduced quality of life, and aggravation of the 
comorbid clinical conditions.1 Growing evidence also reveals 
a significant association between sleep disturbances and an in-
creased risk of suicidal behaviors in both general and clinical 
populations.2–4 However, there have been limited longitudinal 
data examining this association specifically in patients with 
schizophrenia. Given that suicide is a leading cause of pre-
mature death, accounting for 12% of the excessive mortality 
among schizophrenia patients,5 there is a need to investigate 
the link between sleep disturbances and suicidal risk in this 
clinical population.
Sleep disturbances are often implicated in the clinical 
course of psychosis. For example, insomnia is one of the 
most common prodromal symptoms preceding a psychotic 
episode6; it may exacerbate during the acute phase of the ill-
ness or may present as a residual symptom in the clinically 
stabilized patients.7 Recent evidence also suggests a link be-
tween the presence of insomnia and a particular dimensional 
psychotic experience, notably paranoia, in both clinical and 
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Significance
Suicide is the leading cause of premature death among patients with schizophrenia. Timely identification of the individuals at risk of suicide remains a 
major challenge for clinicians. This is the first study to illustrate the risk over time of suicidal behaviors in relation to sleep complaints in individuals with 
schizophrenia spectrum disorders. Sleep disturbances, including insomnia and nightmares, were found to predict an increased risk of suicide attempts in 
outpatients with schizophrenia spectrum disorders. This prognostic implication underscores the need to timely assess and address sleep disturbances in 
this clinical population. Future research is needed to examine the efficacy of sleep-focused treatments in managing sleep disturbances in the context of 
psychotic disorders.
general populations.8,9 Nonetheless, there is a relative pau-
city of data on the prevalence of sleep disturbances, including 
insomnia and nightmares, in patients with schizophrenia, as 
most previous studies were focused on polysomnographic and 
actigraphic sleep features of patients with schizophrenia in 
selected small samples using case-control design.10–13 To ad-
dress the limitations of the existing literature, the objectives 
of the current study were to examine the prevalence of sleep 
disturbances, particularly frequent insomnia and nightmares, 
and their prospective associations with the risk of suicide at-
tempts in patients in whom schizophrenia spectrum disorders 
were diagnosed.
METHODS
Participants
The current study was an 8-y observational study on a con-
secutively recruited cohort of psychiatric outpatients in whom 
schizophrenia-spectrum disorders were diagnosed. All the 
participants provided their written informed consent. The 
study protocol was approved by the Joint Chinese University 
of Hong Kong-New Territories East Cluster Clinical Research 
Ethics Committee.
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The baseline assessment was a part of a clinical epidemio-
logic study on the sleep problems among psychiatric patients 
conducted in the psychiatric outpatient clinic of a regional 
university-affiliated public hospital, which served 8.9% (0.6 
million) of the total population of Hong Kong. A detailed de-
scription of the study design and recruitment at baseline has 
been reported elsewhere.4,14 In brief, all eligible patients aged 
18–65 y attending the clinic consecutively during the 4-w re-
cruitment period in May–June 2006 were invited to take part 
in the baseline study, which involved a sleep questionnaire as-
sessment. Patients were excluded if they: (1) were unable to 
provide a valid informed consent; (2) had an intellectual dif-
ficulty or organic brain syndrome; (3) had a hearing or speech 
deficit; or (4) were attending the university-affiliated sleep 
clinic, which is a part of the psychiatric department. A total of 
1,235 psychiatric outpatients (female: 68.1%; mean age: 42.4 y, 
standard deviation [SD] 11.3 y) were recruited at baseline, and 
388 patients (31.4%) in whom schizophrenia spectrum disor-
ders had been diagnosed in this cohort were the target study 
population of the current study.
Measurements
Instrument
The sleep questionnaire used in the current study has been val-
idated locally as a measure of different sleep problems among 
psychiatric patients.14 It included items to assess demography, 
lifestyle practice, sleep habit, and specific sleep problems, in-
cluding insomnia and nightmares, and was designed to mea-
sure sleep problems on the basis of lifetime occurrence and 
frequency over the past year. Frequency of sleep disturbances 
over the previous year was rated on a five-point scale (0 = none, 
1 = rarely, 2 = at least once a month, 3 = once or twice a week, 
4 = at least three times a week). The sleep questionnaire has 
been shown to have satisfactory psychometric properties.14 
The sensitivity, specificity, positive predictive value (PPV), 
and negative predictive value (NPV) of the overall question-
naire were 0.92, 0.83, 0.88, and 0.88, respectively. In line with 
the previous research,4,15–17 frequent insomnia was defined 
as having one or more of the following sleep problems with 
the frequency of at least three times a week in the past year: 
difficulty initiating sleep, difficulty maintaining sleep, and 
early morning awakening. Frequent nightmares were defined 
as having nightmares of at least once a week in the past year. 
Frequency of alcohol consumption and drug compliance was 
assessed on a three-point scale (0 = never, 1 = sometimes, 
2 = always).
Case Note Information
Each study participant was diagnosed by the attending psy-
chiatrist based on the criteria of the International Classifica-
tion of Diseases, Tenth Revision (ICD-10). Relevant clinical 
information on the study participants was reviewed in the 
Clinical Management System (CMS), an integrated computer-
ized clinical workstation that is implemented in all public hos-
pitals in Hong Kong. The CMS provides comprehensive and 
detailed documentation of the clinical history of a patient who 
is followed up in any public health care sector of Hong Kong. 
Clinical information retrieved from the CMS for the current 
study included the medical history, duration of mental illness, 
and prescription of psychotropic medications. Period of obser-
vation was from June 2006 (the date that the participants com-
pleted the baseline questionnaire assessment) to October 2014. 
Documentation of any suicide attempt in the case notes during 
the study period was used to analyze the prospective associa-
tion between sleep disturbances, as reported in the baseline as-
sessment in 2006, and suicide attempts over the 8-y follow-up 
period. To reduce the potential for bias, the investigator was 
blind to the baseline sleep status of the study participants when 
conducting the case note review. A suicide attempt was de-
fined as a deliberate act of self-harm with the intention to end 
one’s life.4,18 All the clinical records and documentation in the 
CMS were reviewed. These included the progress notes from 
the outpatient clinics of all specialties where the patients had 
any medical or psychiatric follow-up appointments, inpatient 
psychiatric admission notes and discharge summary, as well 
as the medical notes following the attendance to the emergency 
department. Psychotherapy notes were not included as these 
were not routinely entered into the computerized system. The 
clinical notes where self-injury was documented were specifi-
cally reviewed, and the written description of the index inci-
dent was examined thoroughly for evidence of suicide attempt, 
i.e., an intention to end one’s life. Examples of suicide attempts 
included: self-inflicted poisoning (ICD-10 code X60-69), self-
inflicted injury by cutting and piercing instruments (ICD-10 
code X78, X79), self-inflicted injury by hanging, strangulation, 
and suffocation (ICD-10 code X70), and self-inflicted injury by 
jumping from places (ICD-10 code X80).
Statistical Analysis
Chi-square analyses or t-tests, where appropriate, were used 
to determine the significant differences in the demographic 
and clinical characteristics between the participants with and 
without sleep disturbances at baseline. The index date was the 
date of the participants completing the baseline questionnaire 
assessment. The primary end point was an incident of suicide 
attempt as documented in the case notes of the CMS. Obser-
vations were censored in the survival analysis for the cases 
that were lost to follow-up (e.g., no longer had any updated 
medical records shown in the CMS or no longer had any type 
of follow-up appointment in the public health care sector of 
Hong Kong) or had died (cause of death unrelated to a suicide 
attempt). The date of the last primary or speciality care follow-
up of the study participants in the public health care sector was 
used as the censoring date. Kaplan-Meier curves were used 
to depict the cumulative probability of suicide attempt during 
the follow-up period between the participants with and without 
sleep disturbances reported at baseline. Survival curves were 
compared using the log-rank test. Cox proportional hazards re-
gression models were used to examine the association between 
the sleep disturbances and incidents of suicide attempt while 
controlling for the potential confounders and effect modifiers. 
These variables were selected based on the initial univariate 
and bivariate statistical results, as well as the potential rela-
tionships, as reported in the previous studies.19 Selected covari-
ates included the baseline demographics (age, sex) and relevant 
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clinical factors (i.e., duration of mental illness, subtype of 
psychotic disorders, prescription of benzodiazepines and anti-
depressants, past history of suicide attempt(s) and hospitaliza-
tions prior to the baseline questionnaire assessment, and use of 
more than one psychotropic medication). Relative risks were 
expressed as hazard ratios (HRs) with 95% confidence inter-
vals (CIs). All statistical analyses were undertaken using the 
software Statistical Package for the Social Sciences, Version 
16.0 for Windows (SPSS Inc., Chicago, IL). Statistical signifi-
cance was set at 0.05 (two-tailed).
RESULTS
The study sample comprised 388 patients in whom schizo-
phrenia spectrum disorders were diagnosed (Table 1 and 
Table 2). At the time that the case notes were reviewed, 369 
patients (95.1%) continued to attend regular medical or psy-
chiatric follow-up appointments, 6 patients (1.5%) did not have 
any accessible medical record as they were no longer followed 
up in the public health care sector, and 13 patients (3.4%) were 
deceased during the follow-up period due to a medical condi-
tion (e.g., cancer) or an accident (e.g., hiking accident) that was 
not considered as a suicide attempt. Seventeen patients (4.4%) 
have attempted suicide but there was no completed suicide 
during the follow-up period.
The 1-y prevalence of frequent insomnia and frequent 
nightmares at baseline was 19.3% and 9.0%, respectively. 
Comorbid insomnia and nightmare were reported in 3.4% of 
the overall participants. Participants who had frequent night-
mares were more likely to report frequent insomnia (37.1% 
versus 17.6%, χ2 = 7.8, d.f. = 1, P < 0.01). Likewise, partici-
pants with frequent insomnia were more likely to have co-
morbid nightmare disturbances (17.3% versus 7.0%, χ2 = 7.8, 
d.f. = 1, P < 0.01). One-year prevalence of sleep disturbances 
among the participants with different psychotic diagnoses is 
presented in Table 1.
Participants with frequent insomnia were more likely to be 
married (χ2 = 8.0, d.f. = 1, P < 0.01), and were less likely to be 
single (χ2 = 7.8, d.f. = 1, P < 0.01) and have completed a higher 
education (χ2 = 6.6, d.f. = 1, P < 0.05) (Table 2). They were also 
more likely to be prescribed more than one psychotropic medi-
cation (χ2 = 9.6, d.f. = 1, P < 0.01), especially antidepressants 
(χ2 = 4.3, d.f. = 1, P < 0.05) and benzodiazepines (χ2 = 11.2, 
d.f. = 1, P < 0.01), and to report a better drug compliance 
(χ2 = 6.4, d.f. = 1, P < 0.05). Frequent nightmares were found 
to be associated with the comorbid physical illness (χ2 = 5.9, 
d.f. = 1, P < 0.05) (Table 2).
The Kaplan-Meier survival analysis revealed significantly 
higher cumulative incidence of suicide attempt in the group 
of the participants with frequent insomnia at baseline as com-
pared to their counterparts (P < 0.001, log-rank test, Figure 1A). 
Cox regression models further confirmed this observation. 
Frequent insomnia reported at baseline was significantly as-
sociated with the new incidence of suicide attempt during the 
follow-up period after controlling for potential confounding 
factors (adjusted HR = 4.63, 95% CI 1.40–15.36, P < 0.05) 
(Table 3).
Although the complaint of frequent nightmares was associ-
ated with a lifetime history of suicide attempts (42.9% versus 
19.3%, χ2 = 10.5, d.f. = 1, P < 0.01), it did not predict an increased 
risk of suicide attempt over the follow-up period (P = 0.65, log-
rank test, Figure 1B). Further scrutiny of the data revealed a dis-
tinct pattern that the comorbidity of insomnia and nightmare 
disturbances was significantly associated with an increased 
risk of suicide attempts not only in lifetime (P < 0.001, linear-
by-linear association) but also during the 8-y follow-up period 
(P < 0.01, linear-by-linear association) (Figure 2). Cox regres-
sion analysis suggested that the participants who reported 
comorbid insomnia and nightmares at baseline had a greater 
risk of suicide attempts in the following 8 y (crude HR = 7.43, 
95% CI: 1.54–35.81, P < 0.05) as compared to those without 
any sleep disturbances at baseline. This significance persisted 
after adjusting for demographic and clinical confounding fac-
tors (adjusted HR = 11.10, 95% CI: 1.68–73.43, P < 0.05). How-
ever, because of the limited number of cases, the interaction 
between frequent insomnia and frequent nightmares could not 
be tested in the regression model.
DISCUSSION
The current study provides the prevalence and correlates of 
sleep disturbances in a cohort of patients in whom schizo-
phrenia spectrum disorders were diagnosed. To the best of our 
knowledge, this is the first study to illustrate the risk over time 
of suicidal behaviors in relation to sleep complaints in patients 
with schizophrenia spectrum disorders.
Table 1—Prevalence of nocturnal sleep disturbances in relation to ICD-10 diagnosis in the study participants.
Diagnosis n (%) Frequent Insomnia Frequent Nightmares
F20 Schizophrenia 308 (79.4) 52 (16.9) 24 (7.8)
F22 Delusional disorders 16 (4.1) 7 (43.8) 2 (12.5)
F23 Acute & transient psychotic disorders 14 (3.6) 2 (14.3) 1 (7.1)
F24 Induced delusional disorders 1 (0.3) – –
F25 Schizoaffective disorders 26 (6.7) 4 (15.4) 3 (11.5)
F28 Other nonorganic psychotic disorders 11 (2.8) 5 (45.5) 2 (18.2)
F29 Unspecified nonorganic psychosis 12 (3.1) 5 (41.7) 3 (25.0)
Frequent insomnia was defined as having one or more of the following sleep difficulties at least three times per week in the past year: difficulty initiating 
sleep, difficulty maintaining sleep, and early morning awakening. Frequent nightmares were defined as having nightmares at least once per week in the 
past year.
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Table 2—Demographic and clinical characteristics of the study participants.
Characteristics Total (n = 388)
Frequent Insomnia Frequent Nightmares
With (n = 75) Without (n = 313) With (n = 35) Without (n = 353)
Sociodemographic Features
Age, y, mean (SD) 41.0 (11.4) 43.0 (11.3) 40.5 (11.4) 41.3 (11.5) 40.9 (11.4)
Sex, female, n (%) 213 (54.9) 42 (56.0) 171 (54.6) 20 (57.1) 193 (54.7)
Marital status, n (%)
Single 206 (53.1) 29 (38.7)** 177 (56.5) 19 (54.3) 187 (53.0)
Married 137 (35.3) 37 (49.3)** 100 (31.9) 14 (40.0) 123 (34.8)
Divorced/widowed 45 (11.6) 9 (12.0) 36 (11.5) 2 (5.7) 43 (12.2)
Education level, n (%)
Primary or below 95 (24.9) 22 (29.7) 73 (23.7) 8 (23.5) 87 (25.0)
Secondary 237 (62.0) 49 (66.2) 188 (61.0) 23 (67.6) 214 (61.5)
College or above 50 (13.1) 3 (4.1)* 47 (15.3) 3 (8.8) 47 (13.5)
Employment status, unemployed, n (%) 261 (67.8) 55 (73.3) 206 (66.5) 25 (73.5) 236 (67.2)
Lifestyle Practice and Drug Compliance
Alcohol consumption, n (%)
Never 344 (89.1) 65 (86.7) 279 (89.7) 30 (88.2) 314 (89.2)
Sometimes 36 (9.3) 7 (9.3) 29 (9.3) 3 (8.8) 33 (9.4)
Always 6 (1.6) 3 (4.0) 3 (1.0) 1 (2.9) 5 (1.4)
Self-report drug compliance, n (%)
Never 24 (6.2) **–** 24 (7.7) 2 (5.7) 22 (6.2)
Sometimes 10 (2.6) 1 (1.3) 9 (2.9) 1 (2.9) 9 (2.5)
Always 354 (91.2) 74 (98.7)* 280 (89.5) 32 (91.4) 322 (91.2)
Baseline Clinical Characteristics
Duration of mental illness, y, mean (SD) 11.1 (8.6) 11.0 (8.5) 11.1 (8.6) 10.7 (6.7) 11.1 (8.7)
Comorbid physical illness, n (%) 65 (16.8) 15 (20.0) 50 (16.0) 11 (31.4)* 54 (15.3)
Psychotropic medication, n (%)
Antidepressants 54 (13.9) 16 (21.3)* 38 (12.1) 5 (14.3) 49 (13.9)
SSRI 41 (10.6) 11 (14.7) 30 (9.6) 5 (14.3) 36 (10.2)
NaSSA/NDRI 2 (0.5) – 2 (0.6) – 2 (0.6)
TCA 11 (2.8) 4 (5.3) 7 (2.2) – 11 (3.1)
Heterocyclic 2 (0.5) 2 (2.7)* – – 2 (0.6)
Benzodiazepines 119 (30.7) 35 (46.7)** 84 (26.8) 14 (40.0) 105 (29.7)
Nonbenzodiazepines 23 (5.9) 7 (9.3) 16 (5.1) 4 (11.4) 19 (5.4)
Mood stabilizers 55 (14.2) 14 (18.7) 41 (13.1) 8 (22.9) 47 (13.3)
Antipsychotic agents 377 (97.2) 74 (98.7) 303 (96.8) 34 (97.1) 343 (97.2)
Typical antipsychotic agents 239 (61.6) 52 (69.3) 187 (59.7) 22 (62.9) 217 (61.5)
Atypical antipsychotic agents 153 (39.4) 29 (38.7) 124 (39.6) 14 (40.0) 139 (39.4)
Antipsychotic agents with sedative 
properties a
209 (53.9) 45 (60.0) 164 (52.4) 22 (62.9) 187 (53.0)
Depot injection, n (%) 77 (19.8) 17 (22.7) 60 (19.2) 7 (20.0) 70 (19.8)
Use of more than 1 psychotropic 
medications, n (%)
186 (47.9) 48 (64.0)** 138 (44.1) 19 (54.3) 167 (47.3)
Suicidal History
History of suicide attempt(s) prior to the 
baseline assessment, n (%)
72 (18.6) 18 (24.0) 54 (17.3) 13 (37.1)** 59 (16.7)
History of admission in a psychiatric ward 
prior to the baseline assessment, n (%)
266 (68.6) 48 (64.0) 218 (69.6) 23 (65.7) 243 (68.8)
Frequent insomnia was defined as having one or more of the following sleep difficulties at least three times per week in the past year: difficulty initiating 
sleep, difficulty maintaining sleep and early morning awakening. Frequent nightmares were defined as having nightmares at least once per week in the 
past year. a Antipsychotic with moderate to marked sedation including Quetiapine, Olanzapine, Clozapine, Chlorpramazine, Trifuoperazine, Thioridazine, 
Flupenzaine (Miller, 2004; Hyman, Arana, Rosenbarum, 1996). *P < 0.05; **P < 0.01. NaSSA, noradrenergic and specific serotonergic antidepressant; 
NDRI, norepinephrine-dopamine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.
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Sleep Disturbances in 
Schizophrenia-Spectrum Disorders
The prevalence of frequent night-
mares was 9.0% in this study 
sample, which was higher than 
that of the local general adult pop-
ulation (5.1%).16 In a small survey 
conducted in an outpatient clinic, 
16.7% of 54 schizophrenia pa-
tients reported having experienced 
nightmares in the past year, which 
is higher than that of the healthy 
controls (4.9%).20 There have been 
only two studies that reported the 
prevalence of insomnia (36% to 
44%) in the clinically stable schizo-
phrenia outpatients,7,21 which ap-
pears to be relatively higher as 
compared to the percentage (19%) 
found in this study. The discrep-
ancy in the prevalence rates might 
be partly explained by the use of more stringent criteria to 
define the symptomatic timeframe (e.g., past 1 y versus past 
2 w) and the heterogeneity of the clinical samples in different 
studies (e.g., schizophrenia versus schizophrenia spectrum 
disorders). Previous studies based on the polysomnographic or 
actigraphic data have consistently showed a marked sleep dis-
ruption, characterized by difficulty initiating and maintaining 
sleep, in patients with schizophrenia using a case-control de-
sign.10,11,13 Similarly, the prevalence rates of frequent insomnia 
in this clinical cohort across different psychotic diagnoses 
Figure 2—Presence of sleep disturbances at baseline in relation to the incidents of suicide attempt in 
lifetime and during the 8-y follow-up period. *Linear-by-linear association.
Figure 1—Survival curves of time to suicide attempt between the participants with and without frequent sleep disturbances reported at baseline. 
(A) Frequent insomnia reported at baseline in relation to the incident of suicide attempt over the follow-up period. (B) Frequent nightmares reported at 
baseline in relation to the incidents of suicide attempt over the follow-up period.
A B
Table 3—Unadjusted and adjusted Cox regression models for insomnia predicting the incidents of suicide attempt over the 8-y follow-up period.
Frequent insomnia 
reported at baseline
Unadjusted (95% CI) Adjusted (95% CI) a
Hazard Ratio Lower Upper Hazard Ratio Lower Upper
6.51** 2.48 17.12 4.63* 1.40 15.36
a Adjusted for age, sex, duration of mental illness, subtype of psychotic disorders, prescription of antidepressant and benzodiazepine at baseline, use of 
more than 1 psychotropic medication, history of suicide attempt prior to the baseline assessment, history of hospitalisation prior to the baseline assessment. 
*P < 0.05; **P < 0.001. CI, confidence interval.
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(14% to 46%) were found to be variably higher than that of the 
local general adult population (9% to 13%).15,22 Subjective sleep 
disturbances, such as insomnia, may be related to the circadian 
dysregulation often observed in patients with schizophrenia.23 
Further investigation incorporating the measures of circadian 
rhythm would be needed to unravel the potential mechanism 
underlying the sleep disturbances in this clinical population.
Sleep Disturbances in Relation to the Suicidal Risk
Our study confirmed that sleep disturbances confer a greater 
risk for suicide attempts in patients with schizophrenia spec-
trum disorders. In particular, frequent insomnia reported at 
baseline was independently associated with fourfold higher 
incidence of suicide attempt over the longitudinal follow-up. 
Similarly, insomnia was identified as one of the risk factors 
for completed suicide in a retrospective case-control study of 
suicide victims with a diagnosis of schizophrenia.24 Although 
the complaint of frequent nightmares alone did not appear to 
be a significant predictor of suicide attempt in the initial anal-
ysis, the comorbidity of frequent nightmares and insomnia was 
shown to confer an increased risk of future suicide attempt 
(11-fold higher). The observation that sleep disturbances may 
predict the suicidal risk in not only near but also distant fu-
ture may suggest that sleep disturbances might be persistent 
in some patients and represent a proximal risk factor for sui-
cidal behaviors in this clinical population. Community-based 
longitudinal studies suggest that sleep disturbances, such as 
insomnia, once developed, may follow a persistent course in 
40% to 80% of the community-based subjects over 3 to 5 y of 
follow-up.15,25 Nonetheless, there have been limited data that 
documented the longitudinal course of sleep symptoms in pa-
tients with schizophrenia spectrum disorders. Further longitu-
dinal studies are warranted to examine the persistence of sleep 
disturbances in this clinical population.
Our findings are in line with the growing literature sug-
gesting a significant association of the sleep disturbances, in-
cluding insomnia and nightmares, with suicidal behaviors in 
the general and other clinical populations, such as major de-
pression and anxiety disorders.2–4 The mechanistic relationship 
between sleep disruption and suicidal behaviors in the patients 
with schizophrenia and other psychotic disorders remains 
untested, albeit there are several possible pathways. There is 
evidence to suggest an association between sleep disturbances 
and certain psychotic experiences, such as paranoia and com-
mand hallucination,8,26 which may potentially increase the risk 
for suicide. In addition, individuals with sleep disturbances 
are often at an increased risk for the development of depres-
sion,15,16 which is also an independent risk factor for suicide.19 
Thus, it is possible that sleep disturbances may exacerbate 
mood symptoms and psychotic experiences,8,27 rendering the 
individuals more susceptible to engage in suicidal behaviors. 
However, sleep disturbances may contribute to the suicidal risk 
independently by impairing cognitive and executive functions, 
and compromising emotional processing,28,29 thereby leading 
to deficits in problem solving and vulnerability to impulsive 
behaviors.29 Although the clinical severity of the mood symp-
toms and psychotic experiences was not directly assessed in 
this study, several clinical variables were taken into account 
and included in the multivariate models, such as the duration 
of mental illness, prescription of antidepressants, and his-
tory of admission to a psychiatric ward and suicide attempt(s). 
Frequent insomnia and comorbid insomnia and nightmares 
remained significantly associated with new incidence of sui-
cide attempt during the follow-up period, even after adjusting 
for these potentially confounding factors. The findings might 
therefore lend support to the independent role of sleep dis-
turbances in increasing the suicidal risk in the patients with 
schizophrenia-spectrum disorders. Nonetheless, further re-
search is needed to delineate the mechanism underlying the 
relationship between sleep disturbances and risk of suicidal 
behaviors in this clinical population.
Clinical Implications
Schizophrenia is associated with an elevated risk of sui-
cide, with a lifetime rate of completed suicide estimated to 
be 4.9%.30 Timely identification of the individuals at risk of 
suicide remains a major challenge for clinicians. Although 
a number of risk factors for suicide in patients with schizo-
phrenia have been identified, some of these factors (e.g., age, 
sex, family history of suicide) may not be amenable to inter-
vention. In this regard, the prospective association between 
sleep disturbances and suicidal risk found in this study has 
important clinical implications, because sleep disturbances 
are potentially modifiable factors that could be ameliorated 
through proper interventions. Clinical efficacy of sleep-fo-
cused psychological treatments, such as cognitive behavioral 
therapy for insomnia (CBT-I) or imagery rehearsal therapy 
(IRT) for nightmares, has been well established in a variety of 
clinical populations and settings.31,32 A recent study has shown 
that effective treatment of CBT-I reduced suicidal ideation 
even after accounting for the effect of concurrent improve-
ment in the severity of depressive symptoms.33 Although the 
data on the treatment outcome of CBT-I in the context of psy-
chotic disorders remain limited, there have been some prom-
ising results.9,34 Meanwhile, sleep disturbances could be a side 
effect of medication or a residual symptom despite the opti-
mized medication treatment for patients with schizophrenia. 
Different pharmacological approaches have been suggested 
to manage residual sleep disturbances in schizophrenia,35 in-
cluding the use of antipsychotics with sedating properties or 
adding short-term adjunctive medications, such as benzodiaz-
epines or hypnotic agents, to a nonsedating antipsychotic agent. 
However, the evidence base of these treatment approaches is 
limited, and there remains a concern with regard to potentially 
increasing suicide risk by prescribing sedatives and hypnotic 
agents in vulnerable individuals. Of note, 60% of the study 
participants with frequent insomnia were prescribed antipsy-
chotic agents with moderate to marked sedative properties, 
and were more often prescribed benzodiazepines and on poly-
pharmacy treatment, as compared to those without insomnia. 
However, the adjunct pharmacologic treatment did not seem 
to alleviate their sleep problems. Collectively, the findings of 
this study and the existing literature suggest a need for further 
interventional studies to examine the efficacy of sleep-focused 
treatments in managing sleep disturbances in the context of 
psychotic disorders.
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Strengths and Limitations of the Study
The major strength of this study is the follow-up of a large 
consecutive cohort of outpatients in whom schizophrenia 
spectrum disorders were diagnosed in a naturalistic clinical 
setting. These data provided a more realistic picture showing 
the strength of the associations between sleep disturbance and 
suicidal risk in the general clinical practice. Nonetheless, the 
findings of this study should be interpreted with caution in 
light of several methodological caveats. Although a series of 
the variables associated with suicidal risk were included in the 
analysis, some of the risk factors, such as social support net-
work, could not be adequately evaluated in this study. More-
over, the measurement of sleep disturbances in this study was 
based on only self-report without further objective assessment. 
The data on the suicide attempts were based on the review of 
case records, which might have potentially underestimated the 
prevalence and incidence. Incidents might be less likely to be 
documented if the suicide attempts were not severe enough to 
warrant medical treatment or if the patients chose not to dis-
close their act to the attending medical practitioners. However, 
the lifetime prevalence of suicide attempt in this study cohort 
(21.4%) was comparable to that of a previous study based 
on the clinical interview (30.2%).18 Furthermore, the limited 
number of cases precluded further subgroup analyses to ex-
amine whether some of the clinically relevant factors, e.g., pre-
scription of more than one medication and drug compliance, 
would affect the time to first suicide attempt in the follow-up 
period among patients with sleep disturbances at baseline.
CONCLUSION
Sleep disturbances are significantly associated with an in-
creased risk of suicide attempts in schizophrenia spectrum 
disorders. This prognostic implication underscores the need 
for enhanced clinical attention towards sleep problems in pa-
tients with schizophrenia spectrum disorders. Future research 
is needed to examine the efficacy of sleep-focused treatments 
in managing sleep disturbances in this clinical population.
REFERENCES
1. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and 
psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 
1992;49:651–68.
2. Malik S, Kanwar A, Sim LA, et al. The association between sleep 
disturbances and suicidal behaviors in patients with psychiatric 
diagnoses: a systematic review and meta-analysis. Syst Rev 2014;3:18.
3. Pigeon WR, Pinquart M, Conner K. Meta-analysis of sleep 
disturbance and suicidal thoughts and behaviors. J Clin Psychiatry 
2012;73:e1160–7.
4. Li SX, Lam SP, Yu MWM, Zhang J, Wing YK. Nocturnal sleep 
disturbances as a predictor of suicide attempts among psychiatric 
outpatients: a clinical, epidemiologic, prospective study. J Clin 
Psychiatry 2010;71:1440–6.
5. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J 
Psychiatry 1997;171:502–8.
6. Yung A, McGorry P. The prodromal phase of first-episode psychosis: 
past and current conceptualizations. Schizophr Bull 1996;22:353–70.
7. Xiang Y, Weng Y, Leung C, Tang W. Prevalence and correlates of 
insomnia and its impact on quality of life in Chinese schizophrenia 
patients. Sleep 2009;32:105–9.
8. Freeman D, Pugh K, Vorontsova N, Southgate L. Insomnia and 
paranoia. Schizophr Res 2009;108:280–4.
9. Myers E, Startup H, Freeman D. Cognitive behavioural treatment of 
insomnia in individuals with persistent persecutory delusions: a pilot 
trial. J Behav Ther Exp Psychiatry 2011;42:330–6.
10. Chouinard S, Poulin J, Stip E, Godbout R. Sleep in untreated patients 
with schizophrenia: a meta-analysis. Schizophr Bull 2004;30:957–67.
11. Monti J, Monti D. Sleep in schizophrenia patients and the effects of 
antipsychotic drugs. Sleep Med Rev 2004;8:133–48.
12. Martin J, Jeste DV, Caliguiri MP, Patterson T, Heaton R, Ancoli-Israel 
S. Actigraphic estimates of circadian rhythms and sleep/wake in older 
schizophrenia patients. Schizophr Res 2001;47:77–86.
13. Afonso P, Figueira ML, Paiva T. Sleep-wake patterns in schizophrenia 
patients compared to healthy controls. World J Biol Psychiatry 
2014;15:517–24.
14. Lam SP, Fong SYY, Ho CKW, Yu MWM, Wing YK. Parasomnia 
among psychiatric outpatients: a clinical, epidemiologic, cross-
sectional study. J Clin Psychiatry 2008;69:1374–82.
15. Zhang J, Lam SP, Li SX, et al. Long-term outcomes and predictors of 
chronic insomnia: a prospective study in Hong Kong Chinese adults. 
Sleep Med 2012;13:455–62.
16. Li SX, Zhang B, Li AM, Wing YK. Prevalence and correlates of 
frequent nightmares: a community-based 2-phase study. Sleep 
2010;33:774–80.
17. Li SX, Lam SP, Chan JWY, Yu MWM, Wing YK. Residual sleep 
disturbances in patients remitted from major depressive disorder: a 
4-year naturalistic follow-up study. Sleep 2012;35:1153–61.
18. Radomsky ED, Haas GL, Mann JJ, Sweeney JA. Suicidal behavior 
in patients with schizophrenia and other psychotic disorders. Am J 
Psychiatry 1999;156:1590–5.
19. Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. Schizophrenia 
and suicide: systematic review of risk factors. Br J Psychiatry 
2005;187:9–20.
20. Mume CO. Nightmare in schizophrenic and depressed patients. Eur J 
Psychiatry 2009;23:177–83.
21. Palmese LB, DeGeorge PC, Ratliff JC, et al. Insomnia is frequent in 
schizophrenia and associated with night eating and obesity. Schizophr 
Res 2011;133:238–43.
22. Zhang J, Li AM, Kong APS, Lai KYC, Tang NLS, Wing YK. A 
community-based study of insomnia in Hong Kong Chinese children: 
prevalence, risk factors and familial aggregation. Sleep Med 
2009;10:1040–6.
23. Wulff K, Dijk DJ, Middleton B, Foster RG, Joyce EM. Sleep and 
circadian rhythm disruption in schizophrenia. Br J Psychiatry 
2012;200:308–16.
24. Pompili M, Lester D, Grispini A, et al. Completed suicide in 
schizophrenia: evidence from a case-control study. Psychiatry Res 
2009;167:251–7.
25. Morin CM, Belanger L, LeBlanc M, et al. The natural history of 
insomnia: a population-based 3-year longitudinal study. Arch Intern 
Med 2009;169:447–53.
26. Taylor MJ, Gregory AM, Freeman D, Ronald A. Do sleep disturbances 
and psychotic-like experiences in adolescence share genetic and 
environmental influences ? J Abnorm Psychol 2015;124:674–84.
27. Freeman D, Stahl D, McManus S, et al. Insomnia, worry, anxiety and 
depression as predictors of the occurrence and persistence of paranoid 
thinking. Soc Psychiatry Psychiatr Epidemiol 2012;47:1195–203.
28. Yoo SS, Gujar N, Hu P, Jolesz FA, Walker MP. The human emotional 
brain without sleep-a prefrontal amygdala disconnect. Curr Biol 
2007;17:R877–8.
29. Anderson C, Platten CR. Sleep deprivation lowers inhibition 
and enhances impulsivity to negative stimuli. Behav Brain Res 
2011;217:463–6.
30. Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in 
schizophrenia. Arch Gen Psychiatry 2005;62:247–53.
31. Hansen K, Höfling V, Kröner-Borowik T, Stangier U, Steil R. Efficacy 
of psychological interventions aiming to reduce chronic nightmares: a 
meta-analysis. Clin Psychol Rev 2013;33:146–55.
SLEEP, Vol. 39, No. 6, 2016 1282 Sleep Disturbances, Suicide and Schizophrenia—Li et al
32. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein 
KL. Psychological and behavioral treatment of insomnia:update of the 
recent evidence (1998-2004). Sleep 2006;29:1398–414.
33. Trockel M, Karlin BE, Taylor CB, Brown GK, Manber R. Effects 
of cognitive behavioral therapy for insomnia on suicidal ideation in 
veterans. Sleep 2015;38:259–65.
34. Freeman D, Waite F, Startup H, et al. Efficacy of cognitive behavioural 
therapy for sleep improvement in patients with persistent delusions 
and hallucinations (BEST): a prospective , assessor-blind , randomised 
controlled pilot trial. Lancet Psychiatry 2015:2:975–83.
35. Andrade C, Suresh Kumar PN. Treating residual insomnia in 
schizophrenia: examining the options. Acta Psychiatr Scand 
2013;127:11.
SUBMISSION & CORRESPONDENCE INFORMATION
Submitted for publication October, 2015
Submitted in final revised form February, 2016
Accepted for publication February, 2016
Address correspondence to: Yun Kwok Wing, Professor, Director of Sleep 
Assessment Unit, Department of Psychiatry, Shatin Hospital, The Chinese 
University of Hong Kong, Shatin, Hong Kong SAR; Tel: 852-26367748; Fax: 
852-26475321; Email: ykwing@cuhk.edu.hk
DISCLOSURE STATEMENT
This was not an industry-supported study. The authors have indicated no 
financial conflicts of interest.
